Madrigal Pharmaceuticals
MDGL
MDGL
377 hedge funds and large institutions have $12.4B invested in Madrigal Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 62 funds opening new positions, 130 increasing their positions, 128 reducing their positions, and 63 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
2% less funds holding
Funds holding: 386 → 377 (-9)
9% less capital invested
Capital invested by funds: $13.7B → $12.4B (-$1.28B)
38% less funds holding in top 10
Funds holding in top 10: 13 → 8 (-5)
Holders
377
Holding in Top 10
8
Calls
$397M
Puts
$203M
Top Buyers
| 1 | +$207M | |
| 2 | +$200M | |
| 3 | +$112M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$77.4M |
| 5 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$62.3M |
Top Sellers
| 1 | -$151M | |
| 2 | -$108M | |
| 3 | -$76.4M | |
| 4 |
MB
MPM BioImpact
Boston,
Massachusetts
|
-$56.4M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$44.9M |
